Doctors and researchers at the Northwestern Brain Tumor Institute are dedicated to developing clinical trials that provide patients with effective and innovative treatment options. A clinical trial, one of the final stages of a long and careful research process, is a way to prove that a new treatment is safe, effective and/or has fewer side effects than standard brain tumor treatments.
Researchers develop a plan for a clinical trial, also known as a protocol, after laboratory studies indicate that a new treatment, drug or device shows promise. NBTI patients have access to clinical studies offering novel, state-of the art therapies developed by our own physicians, as well as those that are done in cooperation with large, national oncology groups.
The NBTI has also been leading supportive care studies that explore ways to improve the quality of life for patients with brain tumors, as well as the importance of caregivers.
Ask your doctor if you would benefit from one of the many clinical trials open to patients who are looking for the most advanced treatments available.
To learn more about Clinical Trials, read the National Cancer Institute booklet Taking Part in Cancer Treatment Research Studies. It describes how treatment studies are carried out and explains their possible benefits and risks.